journal article Dec 23, 2019

Fentanyl depression of respiration: Comparison with heroin and morphine

British Journal of Pharmacology Vol. 177 No. 2 pp. 254-265 · Wiley
View at Publisher Save 10.1111/bph.14860
Abstract
Background and Purpose
Fentanyl overdose deaths have reached “epidemic” levels in North America. Death in opioid overdose invariably results from respiratory depression. In the present work, we have characterized how fentanyl depresses respiration, and by comparing fentanyl with heroin and morphine, the active breakdown product of heroin, we have sought to determine the factors, in addition to high potency, that contribute to the lethality of fentanyl.


Experimental Approach
Respiration (rate and tidal volume) was measured in awake, freely moving mice by whole body plethysmography.


Key Results
Intravenously administered fentanyl produced more rapid depression of respiration than equipotent doses of heroin or morphine. Fentanyl depressed both respiratory rate and tidal volume. Fentanyl did not depress respiration in μ‐opioid receptor knockout mice. Naloxone, the opioid antagonist widely used to treat opioid overdose, reversed the depression of respiration by morphine more readily than that by fentanyl, whereas diprenorphine, a more lipophilic antagonist, was equipotent in reversing fentanyl and morphine depression of respiration. Prolonged treatment with morphine induced tolerance to respiratory depression, but the degree of cross tolerance to fentanyl was less than the tolerance to morphine itself.


Conclusion and Implications
We propose that several factors (potency, rate of onset, lowered sensitivity to naloxone, and lowered cross tolerance to heroin) combine to make fentanyl more likely to cause opioid overdose deaths than other commonly abused opioids. Lipophilic antagonists such as diprenorphine may be better antidotes than naloxone to treat fentanyl overdose.
Topics

No keywords indexed for this article. Browse by subject →

References
59
[16]
EMCDDA(2018).Fentanils and synthetic cannabinoids: Driving greater complexity into the drug situation.https://webarchiveorg/web/20190213103824/http://wwwemcddaeuropaeu/system/files/publications/8870/2018-2489-td0118414ennpdfArchived 13‐2‐19.
[21]
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

Simon D Harding, Joanna L Sharman, Elena Faccenda et al.

Nucleic Acids Research 10.1093/nar/gkx1121
[22]
HillR.(2019).Polydrug opioid abuse and mechanisms of tolerance to opioid respiratory depression. PhD thesis University of Bristol.
[27]
Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects

A. Kliewer, F. Schmiedel, S. Sianati et al.

Nature Communications 10.1038/s41467-018-08162-1
[37]
NIH(2019).National drug overdose deaths.https://webarchiveorg/web/20190213103737/https://wwwdrugabusegov/related-topics/trends-statistics/overdose-death-ratesArchived 13–2‐19.
[38]
Paronis C. A. "Development of tolerance to the analgesic activity of μ agonists after continuous infusion of morphine, meperidine or fentanyl in rats" The Journal of Pharmacology and Experimental Therapeutics (1992)
[43]
Rang H. P. (2016)

Showing 50 of 59 references

Cited By
181
British Journal of Pharmacology
Trends in Pharmacological Sciences
Metrics
181
Citations
59
References
Details
Published
Dec 23, 2019
Vol/Issue
177(2)
Pages
254-265
License
View
Cite This Article
Rob Hill, Rakulan Santhakumar, William Dewey, et al. (2019). Fentanyl depression of respiration: Comparison with heroin and morphine. British Journal of Pharmacology, 177(2), 254-265. https://doi.org/10.1111/bph.14860
Related

You May Also Like